SAT0405 Disease Activity and Clinical Response Early in the Course of Treatment PREDICT Long-Term Outcomes in Psoriatic Arthritis Patients Treated with Certolizumab Pegol
SAT0405 Disease Activity and Clinical Response Early in the Course of Treatment PREDICT Long-Term Outcomes in Psoriatic Arthritis Patients Treated with Certolizumab Pegol